Behandling af neuroendokrine gastrointestinale tumorer

Keyphrases

• Neuroendocrine Tumor 100%
• Gastrointestinal Tract 100%
• Phase II Study 50%
• Chemotherapy 50%
• Radical Surgery 50%
• Interferon-α (IFN-α) 50%
• Hepatic Metastasis 50%
• Palliative Therapy 50%
• Biotherapy 50%
• Pancreas 50%
• 5-year Survival 50%
• Tumor-targeted Therapy 50%
• MTOR Inhibitor 50%
• Tyrosine Kinase Inhibitor 50%
• Monoclonal Antibody 50%
• Metastasis 50%
• Intra-arterial 50%
• Arterial Embolization 50%
• Inhibitor Antibodies 50%

Medicine and Dentistry

• Neuroendocrine Tumor 100%
• Gastrointestinal Tract 100%
• Neoplasm 50%
• Symptomatic Treatment 50%
• Metastatic Carcinoma 50%
• Radical Surgery 50%
• Liver Metastasis 50%
• Targeted Therapy 50%
• Tyrosine-Kinase Inhibitor 50%
• Monoclonal Antibody 50%
• Interferon Alfa 50%
• Biological Therapy 50%
• Mammalian Target of Rapamycin Inhibitor 50%
• Arterial Embolization 50%